|
Maturity onset diabetes mellitus in young
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
MODY is genetically heterogeneous with five different genes identified to date: hepatocyte nuclear factor-4 alpha (HNF-4 alpha) [MODY1]; glucokinase [MODY2]; hepatocyte nuclear factor-1 alpha (HNF-1 alpha) [MODY3]; insulin promoter factor-1 (IPF-1) [MODY4]; and hepatocyte nuclear factor-1 beta (HNF-1 beta) [MODY5].
|
11058894 |
2000 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Mutations in NEUROD1, PDX1 (IPF1), CEL and INS are rare causes of MODY.
|
21521318 |
2011 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
IPF1 mutations leading to synthesis of a mutant protein may contribute to the development of familial early-onset diabetes/maturity-onset diabetes of the young in Indo-Trinidadians.
|
14764823 |
2004 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Homozygous loss-of-function mutations in the gene coding for the homeobox transcription factor PDX1 leads to pancreatic agenesis, whereas certain heterozygous point mutations are associated with Maturity-Onset Diabetes of the Young 4 (MODY4) and Type 2 Diabetes Mellitus (T2DM).
|
27879214 |
2016 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
The majority of proteins associated with MODY are transcription factors, such as hepatocyte nuclear factor 4alpha (HNF-4alpha), HNF-1alpha, insulin promoter factor-1 (IPF-1), HNF-1beta, and NEUROD1.
|
15955369 |
2005 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
Biomarker
|
disease |
BEFREE |
Important clinical findings were evidenced in some cases after genetic diagnosis, such as MODY-PDX1/HNF1B.
|
31595705 |
2019 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
Biomarker
|
disease |
BEFREE |
Mutations in four genes have been shown to cause MODY: glucokinase, hepatic nuclear factor 1 alpha (HNF1alpha), hepatic nuclear factor 4 alpha (HNF4alpha) and insulin promoter [corrected] factor 1 (IPF1).
|
9472859 |
1998 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
We conclude that variants in IPF-1 are not a common cause of MODY or late-onset type 2 diabetes in the Caucasian population, and that in terms of insulin transcription both the N76 and the T140 mutations are likely to represent functionally normal IPF-1 variants with no direct role in the pathogenesis of MODY or late-onset type 2 diabetes mellitus.
|
10720084 |
2000 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
Biomarker
|
disease |
BEFREE |
Mutations in the genes encoding the glycolytic enzyme glucokinase, the liver-enriched transcription factors, hepatocyte nuclear factor-1alpha (HNF-1alpha), HNF-1beta and HNF-4alpha, and the transcription factor, insulin promoter factor-1 (IPF-1) have all been associated with MODY.
|
9736233 |
1998 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
We propose that IPF-1 mutations can cause MODY or apparently monogenic late-onset diabetes and that they represent a significant risk factor for type 2 diabetes in humans.
|
10545531 |
1999 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
MODY is both clinically and genetically heterogeneous, with six different genes identified to date; glucokinase (GCK), hepatocyte nuclear factor-1 alpha (HNF1A, or TCF1), hepatocyte nuclear factor-4 alpha (HNF4A), insulin promoter factor-1 (IPF1 or PDX1), hepatocyte nuclear factor-1 beta (HNF1B or TCF2), and neurogenic differentiation 1 (NEUROD1).
|
16917892 |
2006 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
Biomarker
|
disease |
BEFREE |
The relative distribution of the 90 families fitting maturity-onset diabetes of the young (MODY) criteria was 63% HNF-1alpha, 2% HNF-4alpha, 0% IPF-1, 1% HNF-1beta, 0% NeuroD1/ BETA2, and 20% glucokinase.
|
11272211 |
2001 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
We demonstrate the significance of this alternative promoter in a large MODY family where a mutated IPF-1 binding site in the P2 promoter of the HNF-4alpha gene co-segregates with diabetes (LOD score 3.25).
|
11590126 |
2001 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Interestingly, functional variants of the MODY 4 gene (insulin promoter factor-1) have been associated with both MODY and the common form of type 2 diabetes.
|
11994901 |
2002 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Recent studies showed that dominant negative mutations in the insulin promoter factor-1 (IPF-1), a pancreatic beta-cell specific transcription factor, cause maturity-onset diabetes of the young (MODY), a subtype of T2DM with early onset and monogenic autosomal inheritance.
|
15754742 |
2004 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
Biomarker
|
disease |
BEFREE |
The identification of mutations in hepatocyte nuclear factors-1alpha, -4alpha, -1beta and insulin promoter factor-1 in maturity onset diabetes of the young (MODY) has highlighted the role that transcription factors may have in the development of diabetes.
|
10230653 |
1999 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Mutations in pdx-1(ipf-1) are associated both with maturity-onset diabetes of the young and type 2 diabetes.
|
15001545 |
2004 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Maturity-Onset Diabetes of the Young (MODY) type 4 or PDX1 -MODY is a rare form of monogenic diabetes caused by heterozygous variants in PDX1 .
|
28436541 |
2018 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
Biomarker
|
disease |
BEFREE |
Mutations in pancreatic duodenal homeobox 1 (PDX-1) can cause a monogenic form of diabetes (maturity onset diabetes of the young 4) in humans, and silencing Pdx-1 in pancreatic β-cells of mice causes diabetes.
|
22570331 |
2012 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
We conclude that mutations in the IPF-1 gene may predispose to type 2 diabetes and are a rare cause of MODY and pancreatic agenesis, with the phenotype depending upon the severity of the mutation.
|
10545530 |
1999 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
Biomarker
|
disease |
BEFREE |
Mutations in 5 different genes [the hepatocyte nuclear factor (HNF)-4alpha), glucokinase, HNF-1alpha, insulin promoter factor-1, and HNF-1beta genes] have been shown to cause maturity onset diabetes of the young (MODY).
|
9920109 |
1999 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, a novel mutation site of MODY type 4 in the PDX1 gene was identified in a family with MODY, which may provide a basis for its clinical treatment.
|
31322178 |
2019 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Homozygous loss-of-function mutations in the gene coding for the homeobox transcription factor PDX1 leads to pancreatic agenesis, whereas certain heterozygous point mutations are associated with Maturity-Onset Diabetes of the Young 4 (MODY4) and Type 2 Diabetes Mellitus (T2DM).
|
27879211 |
2016 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
Biomarker
|
disease |
BEFREE |
Mutations in the transcription factors hepatocyte nuclear factor (HNF)-4alpha and -1alpha, insulin promoter factor-1, and HNF-1beta are the causes of four forms of maturity-onset diabetes of the young (MODY1 and 3-5, respectively).
|
10868948 |
2000 |
|
Maturity onset diabetes mellitus in young
|
0.900 |
Biomarker
|
disease |
BEFREE |
To date, mutations in genes of five proteins have been shown to cause MODY: glucokinase (MODY2), hepatic nuclear factor-1 alpha (HNF-1 alpha) (MODY3), hepatic nuclear factor-4 alpha (HNF-4 alpha) (MODY1), insulin promoter factor 1 (IPF-1) (MODY4) and hepatic nuclear factor-1 beta (HNF-1 beta) (MODY5), but other MODY genes still await elucidation.
|
10417964 |
1999 |